Esperion Therapeutics (ESPR) EBT Growth (1y) (2013 - 2026)
Esperion Therapeutics (ESPR) EBT Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 48.64% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1.94% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -24.84% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -23.88% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1,578.91% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 45.00% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -342.95% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -267.87% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 62.03% |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn | 36.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.48% |
| Dec 31, 2025 | 315.28% |
| Sep 30, 2025 | -2.90% |
| Jun 30, 2025 | -20.16% |
| Mar 31, 2025 | -171.30% |
| Dec 31, 2024 | 49.36% |
| Sep 30, 2024 | 26.85% |
| Jun 30, 2024 | 78.40% |
| Mar 31, 2024 | 192.46% |
| Dec 31, 2023 | -1.02% |
| Sep 30, 2023 | 23.75% |
| Jun 30, 2023 | 22.58% |
| Mar 31, 2023 | -10.41% |
| Dec 31, 2022 | 17.69% |
| Sep 30, 2022 | 19.63% |
| Jun 30, 2022 | -52.58% |
| Mar 31, 2022 | 37.27% |
| Dec 31, 2021 | 33.92% |
| Sep 30, 2021 | 18.81% |
| Jun 30, 2021 | -135.07% |